Kalytera Therapeutics

New York, New York, CanadaFounded 2017

About Kalytera Therapeutics

Kalytera Therapeutics is a biopharmaceutical company focused on developing cannabinoid-based therapeutics for various medical conditions. The company conducts research and development of pharmaceutical products derived from cannabinoids for therapeutic applications.

Key Facts

  • 1Operates as a biopharmaceutical research company
  • 2Focuses on cannabinoid-derived therapeutic products
  • 3Conducts clinical research and development activities
  • 4Has operations spanning New York and Canada

Frequently Asked Questions

What type of company is Kalytera Therapeutics?

Kalytera Therapeutics is a biopharmaceutical company that focuses on developing cannabinoid-based therapeutic products rather than a retail cannabis dispensary.

What is their primary focus?

The company's primary focus is on research and development of pharmaceutical products derived from cannabinoids for various medical applications.

More Cannabis Companies in New York, New York

Products

  • Cannabinoid-based pharmaceutical research
  • Therapeutic drug development
  • Clinical trial programs

Specialties

Biopharmaceutical researchCannabinoid therapeuticsDrug developmentClinical research

Company Details

Founded
2017
Publicly Traded
No
Ticker
:KALY
Browse all Medical & Pharma
View more companies in this category

More in Canada

View all companies in Canada